Standout Papers

Clinical Risk Factors, DNA Variants, and the Development of Type 2 Diabetes 2008 2026 2014 2020 631
  1. Clinical Risk Factors, DNA Variants, and the Development of Type 2 Diabetes (2008)
    Valeriya Lyssenko, Anna Jonsson et al. New England Journal of Medicine

Immediate Impact

4 by Nobel laureates 35 from Science/Nature 62 standout
Sub-graph 1 of 22

Citing Papers

Adipose tissue retains an epigenetic memory of obesity after weight loss
2024 StandoutNature
The benefits of GLP-1 drugs beyond obesity
2024 StandoutScience
2 intermediate papers

Works of Anna Jonsson being referenced

GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study
2015

Author Peers

Author Last Decade Papers Cites
Anna Jonsson 786 848 773 40 2.1k
Bo Isomaa 1204 1102 831 36 2.6k
Stéphane Cauchi 1117 568 953 41 2.4k
Mikko Lehtovirta 522 873 618 38 2.1k
Lars Hansen 783 1126 855 55 2.2k
Ryoko Hagura 580 956 1103 42 2.4k
Carola Saloranta 823 1390 967 39 2.9k
P.M. Blix 667 1247 636 34 2.3k
Rosemary Bland 512 786 605 47 3.0k
Venkatesan Radha 825 817 728 102 2.3k
James L. Rosenzweig 613 1811 702 34 2.8k

All Works

Loading papers...

Rankless by CCL
2026